ATE371463T1 - Ph-sensitive liposomen und andere typen immunomodulatoren enthaltender gekapselter impfstoffe sowie herstellungs- und anwendungsverfahren dafür - Google Patents

Ph-sensitive liposomen und andere typen immunomodulatoren enthaltender gekapselter impfstoffe sowie herstellungs- und anwendungsverfahren dafür

Info

Publication number
ATE371463T1
ATE371463T1 AT98906248T AT98906248T ATE371463T1 AT E371463 T1 ATE371463 T1 AT E371463T1 AT 98906248 T AT98906248 T AT 98906248T AT 98906248 T AT98906248 T AT 98906248T AT E371463 T1 ATE371463 T1 AT E371463T1
Authority
AT
Austria
Prior art keywords
methods
encapsuled
types
production
vaccines containing
Prior art date
Application number
AT98906248T
Other languages
English (en)
Inventor
Jean-Claude Bystryn
Original Assignee
Jean-Claude Bystryn
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Jean-Claude Bystryn filed Critical Jean-Claude Bystryn
Application granted granted Critical
Publication of ATE371463T1 publication Critical patent/ATE371463T1/de

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/0005Vertebrate antigens
    • A61K39/0011Cancer antigens
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/10Dispersions; Emulsions
    • A61K9/127Liposomes
    • A61K9/1271Non-conventional liposomes, e.g. PEGylated liposomes, liposomes coated with polymers
    • A61K9/1272Non-conventional liposomes, e.g. PEGylated liposomes, liposomes coated with polymers with substantial amounts of non-phosphatidyl, i.e. non-acylglycerophosphate, surfactants as bilayer-forming substances, e.g. cationic lipids
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/51Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/515Animal cells
    • A61K2039/5156Animal cells expressing foreign proteins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/555Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511Organic adjuvants
    • A61K2039/55522Cytokines; Lymphokines; Interferons
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/555Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511Organic adjuvants
    • A61K2039/55555Liposomes; Vesicles, e.g. nanoparticles; Spheres, e.g. nanospheres; Polymers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/80Vaccine for a specifically defined cancer
    • A61K2039/876Skin, melanoma

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Microbiology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Oncology (AREA)
  • Engineering & Computer Science (AREA)
  • Mycology (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Food Science & Technology (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Biophysics (AREA)
  • Hospice & Palliative Care (AREA)
  • Dispersion Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)
AT98906248T 1997-02-05 1998-02-05 Ph-sensitive liposomen und andere typen immunomodulatoren enthaltender gekapselter impfstoffe sowie herstellungs- und anwendungsverfahren dafür ATE371463T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US3721797P 1997-02-05 1997-02-05

Publications (1)

Publication Number Publication Date
ATE371463T1 true ATE371463T1 (de) 2007-09-15

Family

ID=21893112

Family Applications (1)

Application Number Title Priority Date Filing Date
AT98906248T ATE371463T1 (de) 1997-02-05 1998-02-05 Ph-sensitive liposomen und andere typen immunomodulatoren enthaltender gekapselter impfstoffe sowie herstellungs- und anwendungsverfahren dafür

Country Status (4)

Country Link
EP (1) EP0983086B1 (de)
AT (1) ATE371463T1 (de)
DE (1) DE69838324T2 (de)
WO (1) WO1998033520A1 (de)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2317549C (en) 1998-01-05 2006-04-11 University Of Washington Composition for enhancing transport through lipid-containing membranes, and uses thereof
US7737108B1 (en) 2000-01-07 2010-06-15 University Of Washington Enhanced transport using membrane disruptive agents
US7361329B2 (en) * 2000-04-21 2008-04-22 Chemocentryx, Inc. Compositions for inducing an immune response
US20030124160A1 (en) * 2001-10-12 2003-07-03 Petrescu Stefana M. Targeted drug delivery
EP1374893A1 (de) 2002-06-17 2004-01-02 NovImmune S.A. Impfung mit Immuno-isolierten Zellen die einen Immunomodulator Produzieren
US20040197392A1 (en) * 2003-01-10 2004-10-07 Knut-Egil Loekling pH-sensitive liposomes
WO2008088581A2 (en) * 2006-08-02 2008-07-24 United Therapeutics Corporation Liposome treatment of viral infections
JP2012521981A (ja) 2009-03-27 2012-09-20 ザ チャンセラー,マスターズ アンド スカラーズ オブ ザ ユニバーシティ オブ オックスフォード コレステロールレベル低下リポソーム
AU2015364447B2 (en) 2014-12-17 2021-04-01 Sri International Antigen delivery system
WO2017064571A1 (en) 2015-09-25 2017-04-20 Maxivax Sa Vaccination with immuno-isolated cells producing an immunomodulator

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5591632A (en) * 1987-03-02 1997-01-07 Beth Israel Hospital Recombinant BCG
JP2849632B2 (ja) * 1988-04-08 1999-01-20 社団法人北里研究所 ワクチン製剤
US5422120A (en) * 1988-05-30 1995-06-06 Depotech Corporation Heterovesicular liposomes
EP0596032B2 (de) * 1991-07-25 2004-04-07 Idec Pharmaceuticals Corporation Anregung von antworten zytotoxischer t-lymphozyten

Also Published As

Publication number Publication date
EP0983086B1 (de) 2007-08-29
DE69838324D1 (de) 2007-10-11
DE69838324T2 (de) 2008-05-15
EP0983086A4 (de) 2004-11-17
EP0983086A1 (de) 2000-03-08
WO1998033520A1 (en) 1998-08-06

Similar Documents

Publication Publication Date Title
HUP0303854A2 (hu) Szintetikus erythropoiesis-stimuláló proteinek
HUP0203056A1 (hu) Vakcinakészítmény
ATE269295T1 (de) Btk inhibitoren und verfahren zur identifizierung und verwendung
DK0758248T3 (da) Formuleringer til faktor IX
DK0760848T3 (da) Lactobacillusstammer af menneskelig oprindelse, deres sammensætninger og anvendelse deraf
ATE337399T1 (de) Zusammensetzungen zur immuntherapie und diagnose von tuberculosis
NO20002788D0 (no) Nye forbindelser
CY1105963T1 (el) Συνθεσεις καψομepιδιακου εμβολιου του ιου του θηλωματος και μεθοδοι χρησης
SE9802729D0 (sv) Novel Compounds
MX9204661A (es) Compuestos intermedios derivados de eter y procedimiento para su preparacion.
DK1200418T3 (da) Nematodicide trifluorbutener
DK1149905T3 (da) Fremgangsmåder og præparat til polypeptidteknologi
DE69620877D1 (de) Arzneimittelformulierungen für il-12
TR199901282T2 (xx) Heterosiklik olarak ikame edilmi� yeni benzamitler.
ES8504246A1 (es) Un metodo para la preparacion de las proteasas fibrinoliticamente activas
MY106202A (en) Saccharin derivatives useful as proteolytic enzyme inhibitors and preparation thereof.
ATE348613T1 (de) Zolpidem hemitartrat solvat
ATE371463T1 (de) Ph-sensitive liposomen und andere typen immunomodulatoren enthaltender gekapselter impfstoffe sowie herstellungs- und anwendungsverfahren dafür
ATE38036T1 (de) Benzothiophenderivate als bronchodilatoren.
ATE293595T1 (de) Thyroidhormon-analoga und verfahren zu ihrer herstellung
DE3681946D1 (de) Zahnfaeuleschutzpraeparate und verfahren zur herstellung derselben.
DK0786004T3 (da) Kloning, ekspression og karakterisering af en hidtil ukendt form af phosphatidylinositol-3-kinase
TR200000697T2 (tr) İkame edilmiş 1,2,3,4,5,6-Heksahidro-2,6-Metano-3-Benzazosin-10-OL'ler, üretim yöntemleri ve farmasötik preparat olarak kullanımları.
DE68912809D1 (de) Verfahren zur Herstellung von Bis(2,2,6,6-tetramethyl-4-piperidyl)amin.
PT80221B (en) Improved process for preparing benzamide derivatives useful as anticonvulsant agents

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties